Prostat Kanseri: Epidemiyoloji, Etiyoloji ve Korunma Yöntemleri
Özet
Prostat kanseri, erkeklerde en sık görülen ikinci kanser türü olup, insansı yaşla birlikte katlanarak artan küresel bir sağlık sorunudur. Tanı anında genellikle PSA yüksekliği ile tespit edilen hastalıkta ailesel öykü ve genetik faktörler riski önemli ölçüde artırmaktadır. Etnik köken, özellikle Afrikalı erkeklerde insidans ve mortalite oranlarının daha yüksek olmasıyla belirgin bir etmendir. Yaşam tarzı faktörlerinden ağır sigara kullanımı mortalite ve nüks riskini artırırken, obezite ve metabolik sendrom agrasif hastalık ve biyokimyasal nüks ile ilişkili bulunmuştur. Beslenme alışkanlıklarında likopen (domates, karpuz vb.) ve soya tüketiminin riski azaltabileceğine dair veriler mevcutken, yüksek kalsiyum alımı risk artışıyla ilişkilendirilmiştir. Haftada 2-4 kez ejekülasyon gibi aktif cinsel yaşamın koruyucu etkisi saptanmıştır. Hastalığı önlemeye yönelik kemoprevensiyon çalışmalarında finasterid ve dutasterid gibi ajanların prostat kanseri riskini sırasıyla %25 ve %23 oranlarında azalttığı gözlenmiş, ancak selenyum ve E vitamininin koruyucu bir etkisi saptanmamıştır. Sonuç olarak, genetik yatkınlığın yanı sıra diyet, fiziksel aktivite ve zararlı alışkanlıklardan kaçınma gibi modifiye edilebilir faktörler prostat kanserinin önlenmesi ve yönetiminde kritik rol oynamaktadır.
Prostate cancer is the second most common cancer in men and a global health problem with an incidence that increases exponentially with age. Family history and genetic factors significantly increase the risk of the disease, which is usually detected by elevated PSA at diagnosis. Ethnicity is a prominent factor, with higher incidence and mortality rates especially among African men. Among lifestyle factors, heavy smoking increases the risk of mortality and recurrence, while obesity and metabolic syndrome are associated with aggressive disease and biochemical recurrence. Regarding dietary habits, data suggest that lycopene and soy consumption may reduce the risk, whereas high calcium intake is linked to increased risk. A protective effect has been found with an active sexual life, such as ejaculation 2-4 times a week. In chemoprevention studies aimed at preventing the disease, agents like finasteride and dutasteride were observed to reduce the risk of prostate cancer by 25% and 23% respectively, while selenium and vitamin E showed no protective effect. Consequently, in addition to genetic predisposition, modifiable factors such as diet, physical activity, and avoiding harmful habits play a critical role in the prevention and management of prostate cancer.
Referanslar
Yao Zhu , Miao Mo , Yu Wei et al. Epidemiology and genomics of prostate cancer in Asian men Nat Rev Uro 2021 May;18(5):282-301
Sung, H., Ferlay, J., Siegel, R. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 2021;71(3), 209-249.
Pernar, C. H., Ebot, E. M., Wilson, K. M., et al. The Epidemiology of Prostate Cancer Cold Spring Harb Perspect Med. 2018 Dec; 8(12), a030361.
TC Sağlık Bakanlığı Türkiye Kanser İstatistikleri 2017 raporu Erişim adresi: http://kanser.gov.tr/Dosya/ca_istatistik/2014-RAPOR._uzun.pdf
Kimura, T., Sato, S., Takahashi, H., et al. (2021). Global trends of latent prostate cancer in autopsy studies. Cancers, 13(2), 359.
Brawley, O.W: Prostate cancer epidemiology in the United States. World J Urol, 30: 195, 2012
Bell, K. J., Del Mar, C., Wright, G., et al.(2015). Prevalence of incidental prostate cancer: A systematic review of autopsy studies. International journal of cancer, 137(7), 1749-1757.
Baltacı, S., Gökçe, İ. Prostat Kanseri. Anafarta,K., Bedük, Y., Arıkan, N. (Ed.). (2011). Temel üroloji. Güneş Kitabevi S 792-820
Parkin, D. M., Bray, F., Ferlay, J., et al. (2005). Global cancer statistics, 2002. CA: a cancer journal for clinicians, 55(2), 74-108.
Hsing, A.W., and Devesa, SS: Trends and patterns of prostate cancer: what do they suggest? Epidemiol. Rev. 23: 3, 2001.
Tarone, R.E., Chu, K.C., and Brawley, O.: Implications of stage specific survival rates in assessing recent declines in prostate cancer mortality rates. Epidemiol. 11: 167, 2000.
Carter, B. S., Bova, G. S., Beaty, T. H., et al.(1993). Hereditary prostate cancer: epidemiologic and clinical features. The Journal of urology, 150(3), 797-802.
Zeegers , jellema A. , Ostrer H. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a metaanalysis. Cancer 2003;97:1894-03
Brandt A, Sundquist J, Hemminki K. 2011. Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer. Ann Oncol 23: 251–256.
Mucci LA, Hjelmborg JB, Harris JR, et al. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. JAMA. 2016;315(1):68–76.
Barber L, Gerke T, Markt SC, et al. Family History of Breast or Prostate Cancer and Prostate Cancer Risk. Clin Cancer Res. 2018;24(23):5910–7.
Amin Al Olama A, Dadaev T, Hazelett DJ, et al. Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. Hum Mol Genet. 2015;24(19):5589–602.
Hemminki, K. Familial risk and familial survival in prostate cancer. World J Urol, 2012. 30: 143.
Bratt, O., Drevin, L., Akre, O., et al. (2016). Family history and probability of prostate cancer, differentiated by risk category: a nationwide population-based study. Journal of the National Cancer Institute, 108(10), djw110.
Howlader N, Noone A, Krapcho M, et al. 2016. SEER Cancer Statistics Review 1975–2013. National Cancer Institute. Bethesda, MD.
Haiman CA, Chen GK, Blot WJ, et al. 2011. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. PLoS Genet 7: e1001387.
Taksler GB, Keating NL, Cutler DM. 2012. Explaining racial differences in prostate cancer mortality. Cancer 118: 4280–4289.
Klein Ea, Silver R . İnflamation, infection, and prostate cancer. Curr Opin Urol. May;18;315-9,2008.
Dennis L.K. , Dawson D. : Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology 13:72,2002
Huncharek M, Haddock KS, Reid R, Kupelnick B. Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. Am J Public Health. 2010;100(4):693–701.
Oefelein MG, Resnick MI. 2004. Association of tobacco use with hormone refractory disease and survival of patients with prostate cancer. J Urol 171: 2281–2284.
Kenfield SA, Stampfer MJ, Chan JM, et al.2011. Smoking and prostate cancer survival and recurrence. JAMA 305: 2548–55.
Zhao J, Stockwell T, Roemer A, et al. Is alcohol consumption a risk factor for prostate cancer? A systematic review and meta-analysis. BMC cancer. 2016;16(1):845.
Platz EA, Giovannucci E. 2004. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. J Steroid Biochem Mol Biol 92: 237–253.
Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res. 2011;4(4):486–501.
Gacci M, Russo GI, De Nunzio C, et al. Meta-analysis of metabolic syndrome and prostate cancer. Prostate Cancer Prostatic Dis. 2017;20(2):146–55.
Sourbeer KN, Howard LE, Andriole GL, et al. Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study. BJU Int. 2015;115(5):736–43.
Sadeghi, A., Sadeghi, O., Khodadost, M., et al. (2020). Dietary glycemic index and glycemic load and the urisk of prostate cancer: an updated systematic review and dose–response meta-analysis. Nutrition and cancer, 72(1), 5-14.
Kenfield SA, Stampfer MJ, Giovannucci E, et al. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol. 2011;29(6):726–32.
Alexander, D. D., Bassett, J. K., Weed, D. L., Barrett, E. C., Watson, H., & Harris, W. (2015). Meta-analysis of long-chain omega-3 polyunsaturated fatty acids (LCω-3PUFA) and prostate cancer. Nutrition and Cancer, 67(4), 543-554.
Lippi, G., & Mattiuzzi, C. (2015). Fried food and prostate cancer risk: systematic review and meta-analysis. International Journal of Food Sciences and Nutrition, 66(5), 587-589.
Etminan M, Takkouche B, Caamano-Isorna F. 2004. The role of tomato products and lycopene in the prevention of prostate cancer: A meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev 13: 340–345.
Ilic, D., & Misso, M. (2012). Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review. Maturitas, 72(4), 269-276.
Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc. 2008;67(3):253–6.
Allen, N. E., Travis, R. C., Appleby, P. N., et al.(2016). Selenium and prostate cancer: analysis of individual participant data from fifteen prospective studies. Journal of the National Cancer Institute, 108(11), djw153.
Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301(1):39–51.
Song, Y., & Ho, E. (2009). Zinc and prostatic cancer. Current opinion in clinical nutrition and metabolic care, 12(6), 640.
Zhang, M., Wang, K., Chen, L.,et al. (2016). Is phytoestrogen intake associated with decreased risk of prostate cancer? A systematic review of epidemiological studies based on 17,546 cases. Andrology, 4(4), 745-756.
Chan JM, Holick CN, Leitzmann MF, et al. Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control. 2006;17(2):199–208.
Richman EL, Stampfer MJ, Paciorek A,et al. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010;91(3):712–21.
Jian Z, Ye D, Chen Y, Li H, Wang K. Sexual Activity and Risk of Prostate Cancer: A Dose-Response Meta-Analysis. J Sex Med. 2018;15(9):1300–9.
Bhindi B, Wallis CJD, Nayan M, et al. The Association Between Vasectomy and Prostate Cancer: A Systematic Review and Meta-analysis. JAMA Intern Med. 2017;177(9):1273–86
Thompson IM, Goodman PJ, Tangen CM, et al. 2003. The influence of finasteride on the development of prostate cancer. N Engl J Med 349: 215–224.
Andriole GL, Bostwick DG, Brawley OW, et al. 2010. Effect of Dutasteride on the risk of prostate cancer. N Engl J Med 362: 1192–1202.
Hadley, C. W., Miller, E. C., Schwartz, S. J., et al. (2002). Tomatoes, lycopene, and prostate cancer: progress and promise. Experimental Biology and Medicine, 227(10), 869-880.
Chhabra, G., Singh, C. K., Ndiaye, M. A., et al.(2018). Prostate cancer chemoprevention by natural agents: Clinical evidence and potential implications. Cancer letters, 422, 9-18.
Neill, M. G., & Fleshner, N. E. (2006). An update on chemoprevention strategies in prostate cancer for 2006. Current opinion in urology, 16(3), 132-137.
Mohseni, R., Abbasi, S., Mohseni, F., et al.(2019). Association between dietary inflammatory index and the risk of prostate cancer: a meta-analysis. Nutrition and cancer, 71(3), 359-366.
Chen, X., Zhao, Y., Tao, Z., et al. (2021). Coffee consumption and risk of prostate cancer: a systematic review and meta-analysis. BMJ open, 11(2), e038902.
